Investigating the intrinsic aggregation potential of evolutionarily conserved segments in p53

Biochemistry

Volumn 53, Issue 38, 2014, Pages 5995-6010

  Ghosh, Saikat ^a   Ghosh, Dhiman ^a   Ranganathan, Srivastav ^a   Anoop, A ^a   Kumar, Santosh P ^a   Jha, Narendra Nath ^a   Padinhateeri, Ranjith ^a   Maji, Samir K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHMS; GLYCOPROTEINS; MOLECULAR DYNAMICS; PEPTIDES; TUMORS;

BIOLOGICAL FUNCTIONS; BIOPHYSICAL TECHNIQUES; DNA BINDING DOMAIN; MOLECULAR DYNAMICS SIMULATIONS; PHYSIOLOGICAL FUNCTIONS; PREDICTION ALGORITHMS; PROTEIN AGGREGATION; TUMOR SUPPRESSORS;

BIOINFORMATICS;

AMYLOID; PILTIITL PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; YFTLQI PROTEIN; DNA; PROTEIN AGGREGATE; PROTEIN BINDING;

ALGORITHM; ARTICLE; ATOM; BIOINFORMATICS; CONTROLLED STUDY; DNA BINDING; HUMAN; IN VITRO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; RAT; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; PROTEINOSIS;

AMINO ACID SEQUENCE; AMYLOID; CONSERVED SEQUENCE; DNA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84907462407     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi500825d     Document Type: Article

References (80)

1. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75, 333-366
2. Maji, S. K., Wang, L., Greenwald, J., and Riek, R. (2009) Structure-activity relationship of amyloid fibrils FEBS Lett. 583, 2610-2617
3. Guijarro, J. I., Sunde, M., Jones, J. A., Campbell, I. D., and Dobson, C. M. (1998) Amyloid fibril formation by an SH3 domain Proc. Natl. Acad. Sci. U.S.A. 95, 4224-4228
4. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., and Dobson, C. M. (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils Proc. Natl. Acad. Sci. U.S.A. 96, 3590-3594
5. Dobson, C. M. (2001) The structural basis of protein folding and its links with human disease Philos. Trans. R. Soc., B 356, 133-145
6. Maji, S. K., Perrin, M. H., Sawaya, M. R., Jessberger, S., Vadodaria, K., Rissman, R. A., Singru, P. S., Nilsson, K. P., Simon, R., Schubert, D., Eisenberg, D., Rivier, J., Sawchenko, P., Vale, W., and Riek, R. (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules Science 325, 328-332
7. Fowler, D. M., Koulov, A. V., Alory-Jost, C., Marks, M. S., Balch, W. E., and Kelly, J. W. (2006) Functional amyloid formation within mammalian tissue PLoS Biol. 4, e6
8. Fowler, D. M., Koulov, A. V., Balch, W. E., and Kelly, J. W. (2007) Functional amyloid: From bacteria to humans Trends Biochem. Sci. 32, 217-224
9. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division Cell 88, 323-331
10. Harris, S. L. and Levine, A. J. (2005) The p53 pathway: Positive and negative feedback loops Oncogene 24, 2899-2908
11. Vousden, K. H. and Lu, X. (2002) Live or let die: The cells response to p53 Nat. Rev. Cancer 2, 594-604
12. Oren, M., Maltzman, W., and Levine, A. J. (1981) Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells Mol. Cell. Biol. 1, 101-110
13. Slade, N. and Moll, U. M. (2003) Mutational analysis of p53 in human tumors: Immunocytochemistry Methods Mol. Biol. 234, 231-243
14. Muller, P. A. J. and Vousden, K. H. (2014) Mutant p53 in Cancer: New Functions and Therapeutic Opportunities Cancer Cell 25, 304-317
15. Dong, P., Karaayvaz, M., Jia, N., Kaneuchi, M., Hamada, J., Watari, H., Sudo, S., Ju, J., and Sakuragi, N. (2013) Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis Oncogene 32, 3286-3295
16. Moll, U. M., LaQuaglia, M., Benard, J., and Riou, G. (1995) Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors Proc. Natl. Acad. Sci. U.S.A. 92, 4407-4411
17. Moll, U. M., Ostermeyer, A. G., Haladay, R., Winkfield, B., Frazier, M., and Zambetti, G. (1996) Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage Mol. Cell. Biol. 16, 1126-1137
18. Moll, U. M., Riou, G., and Levine, A. J. (1992) Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion Proc. Natl. Acad. Sci. U.S.A. 89, 7262-7266
19. Bosari, S., Viale, G., Bossi, P., Maggioni, M., Coggi, G., Murray, J. J., and Lee, A. K. (1994) Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas J. Natl. Cancer Inst. 86, 681-687
20. Bosari, S., Viale, G., Roncalli, M., Graziani, D., Borsani, G., Lee, A. K., and Coggi, G. (1995) p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma Am. J. Pathol. 147, 790-798
21. Ishimaru, D., Andrade, L. R., Teixeira, L. S., Quesado, P. A., Maiolino, L. M., Lopez, P. M., Cordeiro, Y., Costa, L. T., Heckl, W. M., Weissmuller, G., Foguel, D., and Silva, J. L. (2003) Fibrillar aggregates of the tumor suppressor p53 core domain Biochemistry 42, 9022-9027
22. Lee, A. S., Galea, C., DiGiammarino, E. L., Jun, B., Murti, G., Ribeiro, R. C., Zambetti, G., Schultz, C. P., and Kriwacki, R. W. (2003) Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant J. Mol. Biol. 327, 699-709
23. Rigacci, S., Bucciantini, M., Relini, A., Pesce, A., Gliozzi, A., Berti, A., and Stefani, M. (2008) The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies Biophys. J. 94, 3635-3646
24. Butler, J. S. and Loh, S. N. (2003) Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain Biochemistry 42, 2396-2403
25. Lasagna-Reeves, C. A., Clos, A. L., Castillo-Carranza, D., Sengupta, U., Guerrero-Munoz, M., Kelly, B., Wagner, R., and Kayed, R. (2013) Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity Biochem. Biophys. Res. Commun. 430, 963-968
26. Ano Bom, A. P., Rangel, L. P., Costa, D. C., de Oliveira, G. A., Sanches, D., Braga, C. A., Gava, L. M., Ramos, C. H., Cepeda, A. O., Stumbo, A. C., De Moura Gallo, C. V., Cordeiro, Y., and Silva, J. L. (2012) Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: Implications for cancer J. Biol. Chem. 287, 28152-28162
27. Levy, C. B., Stumbo, A. C., Ano Bom, A. P., Portari, E. A., Cordeiro, Y., Silva, J. L., and De Moura-Gallo, C. V. (2011) Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors Int. J. Biochem. Cell Biol. 43, 60-64
28. Nieva, J., Song, B. D., Rogel, J. K., Kujawara, D., Altobel, L., III, Izharrudin, A., Boldt, G. E., Grover, R. K., Wentworth, A. D., and Wentworth, P., Jr. (2011) Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53 Chem. Biol. 18, 920-927
29. Xu, J., Reumers, J., Couceiro, J. R., De Smet, F., Gallardo, R., Rudyak, S., Cornelis, A., Rozenski, J., Zwolinska, A., Marine, J.-C., Lambrechts, D., Suh, Y.-A., Rousseau, F., and Schymkowitz, J. (2011) Gain of function of mutant p53 by coaggregation with multiple tumor suppressors Nat. Chem. Biol. 7, 285-295
30. Forget, K. J., Tremblay, G., and Roucou, X. (2013) p53 Aggregates Penetrate Cells and Induce the Co-Aggregation of Intracellular p53 PLoS One 8, e69242
31. Fernandez-Escamilla, A., Rousseau, F., Schymkowitz, J., and Serrano, L. (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins Nat. Biotechnol. 22, 1302-1306
32. Reumers, J., Maurer-Stroh, S., Schymkowitz, J., and Rousseau, F. (2009) Protein sequences encode safeguards against aggregation Hum. Mutat. 30, 431-437
33. Maurer-Stroh, S., Debulpaep, M., Kuemmerer, N., de la Paz, M. L., Martins, I. C., Reumers, J., Morris, K. L., Copland, A., Serpell, L., Serrano, L., Schymkowitz, J. W., and Rousseau, F. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices Nat. Methods 7, 237-242
34. Conchillo-Sole, O., de Groot, N., Aviles, F., Vendrell, J., Daura, X., and Ventura, S. (2007) AGGRESCAN: A server for the prediction and evaluation of "hot spots" of aggregation in polypeptides BMC Bioinf. 8, 65
35. Rangel, L. P., Costa, D. C. F., Vieira, T. C. R. G., and Silva, J. L. (2014) The aggregation of mutant p53 produces prion-like properties in cancer Prion 8, 75-84
36. Silva, J. L., Gallo, C. V. D. M., Costa, D. C. F., and Rangel, L. P. (2014) Prion-like aggregation of mutant p53 in cancer Trends Biochem. Sci. 39, 260-267
37. Trovato, A., Seno, F., and Tosatto, S. C. E. (2007) The PASTA server for protein aggregation prediction Protein Eng., Des. Sel. 20, 521-523
38. Thompson, M., Sievers, S., Karanicolas, J., Ivanova, M., Baker, D., and Eisenberg, D. (2006) The 3D profile method for identifying fibril-forming segments of proteins Proc. Natl. Acad. Sci. U.S.A. 103, 4074-4078
39. Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Soding, J., Thompson, J. D., and Higgins, D. G. (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega Mol. Syst. Biol. 7, 539
40. Baudot, A., Martin, D., Mouren, P., Chevenet, F., Guenoche, A., Jacq, B., and Brun, C. (2006) PRODISTIN web site: A tool for the functional classification of proteins from interaction networks Bioinformatics 22, 248-250
41. Ayed, A., Mulder, F. A. A., Yi, G.-S., Lu, Y., Kay, L. E., and Arrowsmith, C. H. (2001) Latent and active p53 are identical in conformation Nat. Struct. Mol. Biol. 8, 756-760
42. Jha, N. N., Anoop, A., Ranganathan, S., Mohite, G. M., Padinhateeri, R., and Maji, S. K. (2013) Characterization of Amyloid Formation by Glucagon-Like Peptides: Role of Basic Residues in Heparin-Mediated Aggregation Biochemistry 52, 8800-8810
43. Anoop, A., Ranganathan, S., Dhaked, B. D., Jha, N. N., Pratihar, S., Ghosh, S., Sahay, S., Kumar, S., Das, S., Kombrabail, M., Agarwal, K., Jacob, R. S., Singru, P., Bhaumik, P., Padinhateeri, R., Kumar, A., and Maji, S. K. (2014) Elucidating the role of disulfide bond on amyloid formation and fibril reversibility of somatostatin-14: Relevance to its storage and secretion J. Biol. Chem. 289, 16884-16903
44. LeVine, H., III (1999) Quantification of β-sheet amyloid fibril structures with thioflavin T Methods Enzymol. 309, 274-284
45. Klunk, W. E., Jacob, R. F., and Mason, R. P. (1999) Quantifying amyloid by Congo red spectral shift assay Methods Enzymol. 309, 285-305
46. Westermark, G. T., Johnson, K. H., and Westermark, P. (1999) Staining methods for identification of amyloid in tissue Methods Enzymol. 309, 3-25
47. Maji, S. K., Schubert, D., Rivier, C., Lee, S., Rivier, J. E., and Riek, R. (2008) Amyloid as a depot for the formulation of long-acting drugs PLoS Biol. 6, e17
48. Jarrett, J. T. and Lansbury, P. T., Jr. (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimers disease and scrapie? Cell 73, 1055-1058
49. Barth, A. (2007) Infrared spectroscopy of proteins Biochim. Biophys. Acta 1767, 1073-1101
50. Jackson, M. and Mantsch, H. H. (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure Crit. Rev. Biochem. Mol. Biol. 30, 95-120
51. Ghosh, D., Dutta, P., Chakraborty, C., Singh, P. K., Anoop, A., Jha, N. N., Jacob, R. S., Mondal, M., Mankar, S., Das, S., Malik, S., and Maji, S. K. (2014) Complexation of Amyloid Fibrils with Charged Conjugated Polymers Langmuir 30, 3775-3786
52. Ghosh, D., Mondal, M., Mohite, G. M., Singh, P. K., Ranjan, P., Anoop, A., Ghosh, S., Jha, N. N., Kumar, A., and Maji, S. K. (2013) The Parkinsons Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregation in vitro Biochemistry 52, 6925-6927
53. Klimov, D. K. and Thirumalai, D. (2003) Dissecting the assembly of Aβ(16-22) amyloid peptides into antiparallel β-sheets Structure 11, 295-307
54. Urbanc, B., Cruz, L., Teplow, D. B., and Stanley, H. E. (2006) Computer simulations of Alzheimers amyloid β protein folding and assembly Curr. Alzheimer Res. 3, 493-504
55. Ma, B. and Nussinov, R. (2006) Simulations as analytical tools to understand protein aggregation and predict amyloid conformation Curr. Opin. Chem. Biol. 10, 445-452
56. Ranganathan, S., Singh, P. K., Singh, U., Singru, P. S., Padinhateeri, R., and Maji, S. K. (2012) Molecular Interpretation of ACTH-β-Endorphin Coaggregation: Relevance to Secretory Granule Biogenesis PLoS One 7, e31924
57. Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kale, L., and Schulten, K. (2005) Scalable molecular dynamics with NAMD J. Comput. Chem. 26, 1781-1802
58. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: Visual molecular dynamics J. Mol. Graphics 14, 27-38
59. Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J., Rasool, S., Gurlo, T., Butler, P., and Glabe, C. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers Mol. Neurodegener. 2, 18
60. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300, 486-489
61. Cui, H., Schroering, A., and Ding, H.-F. (2002) p53 Mediates DNA Damaging Drug-induced Apoptosis through a Caspase-9-dependent Pathway in SH-SY5Y Neuroblastoma Cells Mol. Cancer Ther. 1, 679-686
62. Joerger, A. C. and Fersht, A. R. (2008) Structural Biology of the Tumor Suppressor p53 Annu. Rev. Biochem. 77, 557-582
63. Ollmann, M., Young, L. M., Di Como, C. J., Karim, F., Belvin, M., Robertson, S., Whittaker, K., Demsky, M., Fisher, W. W., Buchman, A., Duyk, G., Friedman, L., Prives, C., and Kopczynski, C. (2000) Drosophila p53 is a structural and functional homolog of the tumor suppressor p53 Cell 101, 91-101
64. Schumacher, B., Hofmann, K., Boulton, S., and Gartner, A. (2001) The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis Curr. Biol. 11, 1722-1727
65. van der Wilk, F., Dullemans, A. M., Verbeek, M., and van den Heuvel, J. F. (1999) Isolation and characterization of APSE-1, a bacteriophage infecting the secondary endosymbiont of Acyrthosiphon pisum Virology 262, 104-113
66. Greenfield, N. J. (2007) Analysis of the kinetics of folding of proteins and peptides using circular dichroism Nat. Protoc. 1, 2891-2899
67. Hiramatsu, H. and Kitagawa, T. (2005) FT-IR approaches on amyloid fibril structure Biochim. Biophys. Acta 1753, 100-107
68. Selivanova, G., Ryabchenko, L., Jansson, E., Iotsova, V., and Wiman, K. G. (1999) Reactivation of Mutant p53 through Interaction of a C-Terminal Peptide with the Core Domain Mol. Cell. Biol. 19, 3395-3402
69. Bullock, A. N., Henckel, J., and Fersht, A. R. (2000) Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: Definition of mutant states for rescue in cancer therapy Oncogene 19, 1245-1256
70. Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., and Hainaut, P. (2002) The IARC TP53 database: New online mutation analysis and recommendations to users Hum. Mutat. 19, 607-614
71. Freed-Pastor, W. A. and Prives, C. (2012) Mutant p53: One name, many proteins Genes Dev. 26, 1268-1286
72. Bullock, A. N., Henckel, J., DeDecker, B. S., Johnson, C. M., Nikolova, P. V., Proctor, M. R., Lane, D. P., and Fersht, A. R. (1997) Thermodynamic stability of wild-type and mutant p53 core domain Proc. Natl. Acad. Sci. U.S.A. 94, 14338-14342
73. Ang, H. C., Joerger, A. C., Mayer, S., and Fersht, A. R. (2006) Effects of Common Cancer Mutations on Stability and DNA Binding of Full-length p53 Compared with Isolated Core Domains J. Biol. Chem. 281, 21934-21941
74. Ostermeyer, A. G., Runko, E., Winkfield, B., Ahn, B., and Moll, U. M. (1996) Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide Proc. Natl. Acad. Sci. U.S.A. 93, 15190-15194
75. Giannakakou, P., Sackett, D. L., Ward, Y., Webster, K. R., Blagosklonny, M. V., and Fojo, T. (2000) p53 is associated with cellular microtubules and is transported to the nucleus by dynein Nat. Cell Biol. 2, 709-717
76. Shaulsky, G., Goldfinger, N., Tosky, M. S., Levine, A. J., and Rotter, V. (1991) Nuclear localization is essential for the activity of p53 protein Oncogene 6, 2055-2065
77. Muller, P. A. J. and Vousden, K. H. (2013) p53 mutations in cancer Nat. Cell Biol. 15, 2-8
78. Harper, J. D. and Lansbury, P. T., Jr. (1997) Models of amyloid seeding in Alzheimers disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66, 385-407
79. Jucker, M. and Walker, L. C. (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases Nature 501, 45-51
80. Silva, J. L., Vieira, T. C., Gomes, M. P., Bom, A. P., Lima, L. M., Freitas, M. S., Ishimaru, D., Cordeiro, Y., and Foguel, D. (2010) Ligand binding and hydration in protein misfolding: Insights from studies of prion and p53 tumor suppressor proteins Acc. Chem. Res. 43, 271-279